IRIS
ADINOLFI, Luigi Elio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 8.286
NA - Nord America 7.794
AS - Asia 1.086
Continente sconosciuto - Info sul continente non disponibili 20
AF - Africa 16
SA - Sud America 14
OC - Oceania 3
Totale 17.219
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.757
IE - Irlanda 2.747
UA - Ucraina 1.397
GB - Regno Unito 1.070
IT - Italia 936
DE - Germania 792
CN - Cina 657
SE - Svezia 432
FI - Finlandia 355
TR - Turchia 327
GR - Grecia 232
FR - Francia 209
IN - India 31
CA - Canada 30
BE - Belgio 29
EU - Europa 20
NL - Olanda 19
RO - Romania 19
IR - Iran 17
RU - Federazione Russa 13
SG - Singapore 12
CZ - Repubblica Ceca 10
JP - Giappone 9
ID - Indonesia 7
TW - Taiwan 7
EG - Egitto 6
IL - Israele 6
BR - Brasile 4
KR - Corea 4
MX - Messico 4
PL - Polonia 4
SC - Seychelles 4
CL - Cile 3
CO - Colombia 3
ES - Italia 3
NO - Norvegia 3
PE - Perù 3
PT - Portogallo 3
AU - Australia 2
BG - Bulgaria 2
CH - Svizzera 2
HR - Croazia 2
HU - Ungheria 2
LI - Liechtenstein 2
MK - Macedonia 2
MY - Malesia 2
PK - Pakistan 2
UG - Uganda 2
VN - Vietnam 2
AN - Antille olandesi 1
AR - Argentina 1
BN - Brunei Darussalam 1
BW - Botswana 1
BY - Bielorussia 1
JM - Giamaica 1
MA - Marocco 1
NZ - Nuova Zelanda 1
PA - Panama 1
SA - Arabia Saudita 1
TN - Tunisia 1
TZ - Tanzania 1
UZ - Uzbekistan 1
Totale 17.219
Salva come PNG Salva come JPEG
Città #
Dublin 2.741
Jacksonville 2.126
Chandler 1.337
Princeton 422
Roxbury 316
Bremen 304
Medford 254
Ann Arbor 218
Boardman 216
New York 208
Wilmington 193
Cambridge 186
Woodbridge 186
San Mateo 125
Ashburn 116
Nanjing 108
Beijing 106
Düsseldorf 102
Caserta 96
Des Moines 85
Mountain View 73
Jinan 67
Napoli 65
Shenyang 54
Norwalk 41
Nanchang 40
Venice 33
Naples 32
Brussels 28
Zhengzhou 28
Helsinki 26
Washington 24
Haikou 23
Tianjin 23
Changsha 21
Houston 21
Milan 21
Auburn Hills 18
Hebei 18
Kunming 18
Los Angeles 18
Ningbo 18
Hangzhou 17
Guangzhou 16
Marano Di Napoli 16
Lanzhou 15
Taizhou 15
Redwood City 14
Palermo 12
San Francisco 12
Shanghai 12
Taiyuan 11
Dearborn 10
Perugia 10
Rome 10
Zanjan 10
Andover 9
Groningen 9
Pozzuoli 9
Sacramento 9
Timisoara 9
Elora 8
Fairfield 8
Ottawa 8
Seattle 8
Torino 8
Toronto 8
Bologna 7
Changchun 7
Hefei 7
Jiaxing 7
Paris 7
Philadelphia 7
Amsterdam 6
Duncan 6
Eboli 6
Florence 6
Gioi 6
Orange 6
Pune 6
Sesto Calende 6
Tel Aviv 6
Munich 5
Taipei 5
Atlanta 4
Avellino 4
Bari 4
Cornigliano 4
Grafing 4
Leawood 4
London 4
Modugno 4
Montesarchio 4
Nonantola 4
Toledo 4
Boydton 3
Capriolo 3
Cava De' Tirreni 3
Chennai 3
Dallas 3
Totale 10.593
Salva come PNG Salva come JPEG
Nome #
Sviluppo di un questionario autocompilato per la valutazione delle opinioni dei familiari sulle cause e le conseguenze psicosociali della schizofrenia (QOF) 111
Endocardite da Gemella morbillorum: descrizione di due casi 108
Cannabinoid receptor 2-63 QQ varianti s associated with severe necroinflammation in chronic epatiti C 106
Mechanisms and clinical behavior of hepatocellular carcinoma in HBV and HCV infection and alcoholic and non-alcoholic fatty liver disease 100
Ankle-Brachial Index and cardiovascular events in atrial fibrillation The ARAPACIS Study 94
Epstein Barr virus infection reactivation as a possible trigger of primary biliary cirrhosis-like syndrome in a patient with multiple sclerosis in the course of fingolimod treatment. 89
Hepatocellular carcinoma in chronic HBV-HCV co-infection is correlated to fibrosis and disease duration 89
Clinical efficacy of dirithromycin versus miocamycin in tonsillopharyngitis 87
Bioelectrical impedance analysisfor the assessment of body composition in patients with systemic sclerosis 87
Chronic hepatitis C virus infection and atherosclerosis: clinical impact and mechanisms 81
Ittero in corso di infezione delle vie urinarie. Presentazione di un caso clinico ed aspetti patogenetici 78
Abdominal fat interacts with PNPLA3 I148M, but not with the APOC3 variant in the pathogenesis of liver steatosis in chronic hepatitis C 77
Association Between a Polymorphism in Cannabinoid Receptor 2 and Severe Necroinflammation in Patients With Chronic Hepatitis C. 75
Adiponectin and insulin resistance are related to restenosis and overall new PCI in subjects with normal glucose tolerance: the prospective AIRE Study 75
Ruolo eziologico e patogenetico del virus dell'epatite C (HCV) nella crioglobulinemia mista (CM) in pazienti con epatite cronica (EC). 73
Crioglobulinemia mista essenziale associata a cirrosi epatica: aspetti clinici e terapeutici.Esperienza su una casistica clinica 72
null 71
Anti-envelope 1 and 2 immune response in chronic hepatitis C patients: Effects of hepatitis B virus co-infection and interferon treatment 71
effetto di concentrazioni subinibenti ed effetto intrafagocitico di aztreonam, cefamandolo e netilmicina 70
IMPACT OF TYPE II DIABETES ON HCC APPEARANCE IN PATIENTS TREATED WITH DIRECT ACTING ANTIVIRALS 69
Effect of prednisone priming followed by alpha-interferon in treatment of children with chronic hepatitis B: an interim analysis of a controlled trial 68
Chronic HCV Infection is risk of atherosclerosis. Role of HCV and HCV-related steatosis 68
Antimicrobici e sistema immune dell'ospite: bioattività intrafagocitica di antibiotici beta-lattamici 67
The impact of the CB2-63 polymorphism on the histological presentation of chronic hepatitis B. 66
Chronic HCV infection and neurological and psychiatric disorders: an overview. 63
PNPLA3 l148M variant as a risk factor for carotid atherosclerosis in chronic epatiti C 63
HCV RNA levels in serum, liver and PBMC of chronic hepatitis C patients: pathological and therapeutic significance. 63
Lights and shadows in the management of old and new oral anticoagulants in the real world of atrial fibrillation by Italian internists. A survey from the Atrial Fibrillation Registry for Ankle-Brachial Index Prevalence Assessment-Collaborative Italian Study 62
Pleurite da Listeria monocytogenes in un paziente con cirrosi epatica: osservazione di un caso clinico 61
All-oral interferon-free treatments: The end of hepatitis C virus story, the dream and the reality 61
Sonoporation by microbubbles as gene therapy approach against liver cancer 61
Medication prescription and adherence disparities in non valvular atrial fibrillation patients: an Italian portrait from the ARAPACIS study. 60
Le complicanze infettive in pazienti sottoposti a trapianto di cuore: dati del centro napoletano. 60
Prevention of the toxicity of erythromycin estolate in the perfused rat liver by endotoxin 59
Esperienza con l'interferone linfoblastoide nelle epatiti croniche virali 59
Infective endocarditis due to high-level gentamicin and glycopeptides resistant enterococci: efficacy of the ampicillin-fluoroquinolones combination 59
Celiachia silente in pazienti con epatite C: prevalenza, effetto del trattamento con alfa-interferone sull’attivazione della malattia ed evoluzione clinica 59
Boceprevir or telaprevir in hepatitis C virus chronic infection: The Italian real life experience. 59
Role of interleukin 28-B in the spontaneous and treatment-related clearance of HCV infection in patients with chronic HBV/HCV dual infection 58
Resistance to aminoglycosides and other antibiotics among clinical isolates of Enterococcus spp 58
Treatment of pulmonary nocardiosis in heart-transplant patients: importance of susceptibility studies 58
Activity of aminoglycosides against phagocytosed bacteria 58
Favourable effect of alpha-interferon treatment in HBeAb/HBV-DNA positive chronic hepatitis B. 58
Acute rhabdomiolisys in healthy woman. 58
Characteristics at presentation and outcome of hepatocellular carcinoma (HCC) in the elderly. A study of the Cancer of the Liver Italian Program (CLIP) 57
Leukocyte interferon-alpha and ribavirin for treatment of chronic hepatitis C patients intolerant to pegylated-interferon 57
Endotoxin protects against chlorpromazine-induced cholestasis in the isolated perfused rat liver 57
Cannabinoid Receptor 2 (CB2) Q63 variant in chronic hepatitis C: an association with a more severe hepatocellular necrosis. 57
Antimicrobials and biological activities of immune system. Relazione al " Bologna,pag. 3-10. 57
Disordini immunologici in corso di epatite cronica da HCV: prevalenza significato clinico ed implicazioni terapeutiche. 57
An in-vitro study of treatment of drug-induced cholestasis by tauroursodeoxycholate (TUDC). 57
Aspetti clinico terapeutici della crioglobulinemia mista associata all’epatite cronica C: esperienza su un ampia casistica. 57
Ruolo patogenetico dell'adiponectina nella steatosi associata ad epatite C 57
Patatin-Like Phospholipase Domain-Containing 3 I148M Variant Is Associated with Liver Steatosis and Fat Distribution in Chronic Hepatitis B 57
Interferon-induced anti-HBE seroconversion correlates with a Th1 cytokine shift following emergence of core promoter mutations in chronic hepatitis B 56
Prevalence of antibiotic resistance among clinical isolates of methicillin-resistant staphylococci 56
Le infezioni respiratorie da Branhamella catarrhalis in pazienti sottoposti a trapianto di cuore. 56
Treatment of chronic hepatitis B in children with prednisone followed by alpha-interferon: a controlled randomized study 55
PATHOGENESIS AND SIGNIFICANCE OF HCV STEATOSIS.An update on survival strategy of a successful pathogen 55
Cannabinoid receptor 2 (CB2) Q63 variant is associated with a severe histological activity index in patients with chronic hepatitis C 55
Different serological, molecular and cytokine profiles characterize active and inactive disease in patients with chronic hepatitis B virus (HBV) infection 55
Complicanze infettive in pazienti sottoposti a trapianto di cuore. 55
Effects of long-term alfa interferon treatment in 344 patients with chronic hepatitis C: retrospective analysis of dosage and type of interferon used 54
Effects of bacterial lipopolysaccharide (LPS) on chlorpromazine (CPZ) induced cholestasis in the isolated perfused rat liver 54
Unusually high rate of hepatic comorbidity with Streptococcus bovis endocarditis: trend or coincidence? 54
Favourable effect of alpha-interferon treatment in HBeAb/HBV-DNA positive chronic hepatitis B 54
L'endocardite da Enterococco: nostra esperienza nel periodo 1988-93. 54
CB2-63 polymorphism and immune-mediated diseases associated with HCV chronic infection. 54
Tenofovir disoproxil fumarate monotherapy maintains HBV suppression achieved by a "de novo" combination of lamivudine-adefovir: a pilot study 54
Steatosi associata ad HCV e steatosi metabolica. Patologie diverse o sovrapposte? 53
Problemi diagnostici e terapeutici dell'amebiasi: presentazione di due casi clinici 53
Chronic hepatitis C virus infection and neurological and psychiatric disorders: an overview. 53
Comunicazione orale: Cinetica precoce dell’HCV-RNA in pazienti con epatite cronica: correlati clinico-virologici e valore predittivo la risposta al trattamento antivirale 53
EFFICACIA DEL TRATTAMENTO CON INTERFERONE RICOMBINANTE E LINFOBLASTOIDE IN PAZIENTI CON EPATITE CRONICA DA HCV 53
Interplay between oxidative stress and hepatic steatosis in the progression of chronic hepatitis C 52
Hyperhomocysteinemia and the MTHFR C677T polymorphism promote steatosis and fibrosis in chronic hepatitis C patients. 52
Liver's functional alterations produced from erythromycin estolate in the isolated and perfused rat liver 52
Bacterial endotoxin treatment ameliorates erythromycin estolate-induced cholestasis in the isolated perfused rat liver 52
Chronic endotoxin pretreatment protects from the chlorpromazine induced cholestasis 52
Severe diarrhea occurring during alpha-interferon treatment for chronic hepatitis C is associated with serologic markers of celiac disease 52
Epidemiology, clinical spectrum and prognostic value of mixed cryoglobulinaemia in hepatitis C virus patients: a prospective study 51
Insulin resistance and steatosis in HBV-HCV co-infected patients: Role of PNPLA3 polymorphisms and impact on liver fibrosis progression. 51
Mild chronic hepatitis C with steatosis: Which treatment? 51
Discriminating value of serum bile acids in asymptomatic HBsAg carriers 51
Prevalenza di gentamicina-resistenza (G-R) e suscettibilità antibiotica di enterococchi 51
Major embolic events in infective endocarditis are associated with a younger age 51
Malattie del fegato e delle vie biliari 51
Relationship between low Ankle-Brachial Index and rapid renal function decline in patients with atrial fibrillation: a prospective multicentre cohort study. 51
Epidemiology of HCV and HBV in a High Endemic Area of Southern Italy: Opportunities from the COVID-19 Pandemic—Standardized National Screening or One Tailored to Local Epidemiology? 50
Defective synthesis of granulocyte-colony stimulating factor in pegylated interferon-alpha treated chronic hepatitis C patients with declining leukocyte counts 50
Clinical reactivation during lamivudine treatment correlates with mutations in the precore/core promoter and polymerase regions of hepatitis B virus in patients with anti-hepatitis B e-positive chronic hepatitis 50
Practice guidelines for the diagnosis and management of nonalcoholic fatty liver disease. A decalogue from the Italian Association for the Study of the Liver (AISF) Expert Committee 50
Effect of endotoxin tolerance on drug hepatotoxicity: amelioration of taurolithocholate cholestasis in the perfused rat liver 50
Cholestasis induced by estradiol-17 beta-D-glucuronide: mechanisms and prevention by sodium taurocholate 50
Reduction of taurolithocholic acid-induced cholestasis in the isolated perfused rat liver by endotoxin treatment 50
Potentation of ethanol-induced narcosis in mice by pretreatment with bacterial lipopolysaccharide 50
Bacterial endotoxin effect on liver plasma membranes (LPM): membrane-bound enzymes as probes of the site of interaction 50
Le infezioni delle basse vie urinarie: eziologia e suscettibilità agli antibiotici. Nostra esperienza negli ultimi 4 anni. 50
Ruolo patogenetico dell’adiponectina nella steatosi associata ad epatite C 50
Chronic HCV infection and inflammation: Clinical impact on hepatic and extra-hepatic manifestations. 50
Totale 6.125
Salva come PNG Salva come JPEG
Categoria #
all - tutte 65.061
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 65.061
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201940 0 0 0 0 0 0 0 0 0 0 20 20
2019/20202.164 452 400 40 17 376 44 444 74 141 61 89 26
2020/20213.116 272 32 362 137 651 34 430 358 16 416 309 99
2021/20222.615 145 9 36 63 889 22 30 67 111 220 222 801
2022/20235.330 468 91 67 401 704 413 17 343 2.569 43 105 109
2023/20241.585 152 71 77 175 731 247 36 64 10 22 0 0
Totale 17.797